Lumicell
Surgical Instruments & Devices
$324.1Mtotal raised · 8 rounds on record
3hiring now · +2 posted in 30 days
$198.1Mlatest round · Venture round · Apr 2025 · 18 mo ago
1backers · LaunchCapital
Overview
Incomplete resections are leaving cancer behind. The Lumicell mission is to change the way cancer surgery is performed today.
Funding and backers
Total raised
$324.1M
8 rounds on record
Latest round
$198.1M
Venture round · Apr 2025 · 18 mo ago
Team
40
US Form 5500 (plan participants) · Dec 2025 · +38% in a year
Hiring now
3
+2 posted in 30 days
Grants
$2.4M
2 grants · CORDIS
Backers
1
LaunchCapital
The money's age
Due for its next round
18 months since the last round · and hiring
Momentum
42/100
hiring for its size, in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 28
New executive Lumicell Promotes Marnie Curbow as Chief Commercial Officer to Drive Next Phase of Growth · morningstar.com
Feb 4
Board appointment Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors · lumicell.com
2025
Team of 40 was 29 · US Form 5500 (plan participants)
Dec 18, 2025
Partnership Lumicell Announces Collaboration with Learn Look Locate to Empower Breast Cancer Patients through Lumpectomy Education · lumicell.com
Apr 22, 2025
Raised a round Venture round $198.1M · SEC Form D
Jul 1, 2024
Won a grant $399k · CORDIS
Feb 22, 2024
Raised a round Venture round $2.3M · SEC Form D
Jul 14, 2023
Raised a round Venture round $75.8M · SEC Form D
Dec 7, 2018
Raised a round Venture round $20.4M · SEC Form D
Jun 28, 2017
Raised a round Venture round $20.7M · SEC Form D
Jul 4, 2016
Won a grant $2M · CORDIS
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Apr 2025 | $198.1M | — | SEC Form D |
| Grant | Jul 2024 | $399k | — | CORDIS |
| Venture round | Feb 2024 | $2.3M | — | SEC Form D |
| Venture round | Jul 2023 | $75.8M | — | SEC Form D |
| Venture round | Dec 2018 | $20.4M | — | SEC Form D |
| Venture round | Jun 2017 | $20.7M | — | SEC Form D |
| Grant | Jul 2016 | $2M | — | CORDIS |
| Venture round | Apr 2016 | $6.8M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | LUMICELL, INC. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Andrey ZarurDirectorSEC Form D
W. LeeDirectorSEC Form D
Kelly LondyExecutive Officer, DirectorSEC Form D
Kevin HershbergerExecutive Officer, DirectorSEC Form D
Jorge FerrerExecutive OfficerSEC Form D
Howard HechlerExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Symphera
Similar startupsby what they do, their industry and backers
Ziplyft™ is a patented, minimally invasive upper eyelid lift performed in under 15 minutes with no sutures and minimal downtime. Refresh…
PathKeeper Surgical, Surgical Navigation, Navigated spine surgery.
Petal is a surgical technology company pioneering incisionless surgery through Acoustic Sculpting, a proprietary form of millisecond pulse…
Surgery Reinvented - Current Surgical targets early-stage solid tumors in areas where traditional surgical techniques fail.
Surgery at the Speed of Thought. Stay up to date with the latest announcements, partnerships, and milestones from Symphera.
TRANSFORMING TODAY'S CANCER SURGERY WITH AR - MAKING THE INVISIBLE VISIBLE. Navari has developed a unique, patent-pending technology that…
Growth
Hiring Momentum
28/100
Slowing
Open positions
3
0 opened / 0 closed in 30 days
ATS activity
Every ~6 hours
Today
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
67% ▲
Marketing
33% ▲
Financials
Total raised
$326.5M
Latest round
Venture - Series Unknown
Funding rounds
8
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $198.1M | Details |
| Grant | 2024 | $399k | Details |
| Venture - Series Unknown | 2024 | $2.3M | Details |
| Venture - Series Unknown | 2023 | $75.8M | Details |
| Venture - Series Unknown | 2018 | $20.4M | Details |
| Venture - Series Unknown | 2017 | $20.7M | Details |
| Grant | 2016 | $2M | Details |
| Venture - Series Unknown | 2016 | $6.8M | Details |
People
Andrey Zarur
Director
W. Lee
Director
Kelly Londy
Executive Officer, Director
Kevin Hershberger
Executive Officer, Director
Jorge Ferrer
Executive Officer
Howard Hechler
Executive Officer, Director
David Furneaux
Director
Kevin Krenitsky
Director
Moungi Bawendi
Director
Ralph Weissleder
Director
James Schuermann
Director
Michael Ruettgers
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
LaunchCapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Lumicell Highlights Growing Role of LumiSystem as Commercial Expansion Accelerates, including Implementation at Nation's Leading Cancer Center
Lumicell, Inc., a leader in fluorescence-guided imaging technologies for cancer detection, today highlighted the growing clinical relevance of LumiSystem, the company's real-time intraoperative imaging platform for breast-conserving surgery, as Lumicell c
Read more
Report
Lumicell Highlights Growing Role of LumiSystem as Commercial Expansion Accelerates, including Implementation at Nation
Lumicell, Inc., a leader in fluorescence-guided imaging technologies for cancer detection, today highlighted the growing clinical relevance of LumiSystem, the company
Read more
Report
Lumicell Promotes Marnie Curbow as Chief Commercial Officer to Drive Next Phase of Growth
Lumicell Promotes Marnie Curbow as Chief Commercial Officer to Drive Next Phase of Growth Waltham, MA - Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the promotion of Marni
Read more
Report
Report
Lumicell Showcases Expanded Scientific and Clinical Engagement at ASBrS 2026 Annual Meeting
Seattle, WA - May 1, 2026 - Lumicell, a leader in intraoperative fluorescence imaging technology for breast cancer surgery, announced today its expanded presence at the American Society of Breast Surgeons (ASBrS) 2026 Annual Meeting, taking place April 29
Read more
Report
Lumicell Featured on Health Uncensored with Dr. Drew to Discuss Advances in Breast Cancer Surgery
/PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, announced today that it will...
Read more
Report
Lumicell Featured on Health Uncensored with Dr. Drew to Discuss Advances in Breast Cancer Surgery
Waltham, MA - April 2026 - Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, announced today that it will be featured on Health Uncensored with Dr. Drew, a national health television series ho
Read more
Report
Lumicell Featured on Health Uncensored with Dr. Drew to Discuss Advances in Breast Cancer Surgery
Read more
Report
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors
Newton, MA February 4, 2026 - Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the appointment of Cheryl R. Blanchard, Ph.D., to its Board of Directors. Dr. Blanchard is an ac
Read more
Report
Lumicell Supports Stand Up To Cancer Dream Team for Early Detection of Gastric Cancer with Investigational Device and New Drug
Los Angeles, January 8, 2026 - Global Team Will Launch Gastric Cancer Prevention Clinical Trial. CAUTION - Investigational device and new drug. Limited by Federal (or United States) law to investigational use.Read more The post Lumicell Supports Stand Up
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
3
Hiring now
2
Countries
1
Busiest office
Waltham
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Wellesley
United States
HQ
Waltham
United States
Sales office
1-833-4-LUM-DVS
2 open roles 2 posted in 90 days 200-500 est. staff
hires for Marketing, Sales
Houston
United States
Sales office
1 open roles 1 posted in 90 days 50-200 est. staff
hires for Sales